Miragen Therapeutics found using ticker (MGEN) have now 4 analysts covering the stock. The analyst consensus points to a rating of ‘Buy’. The target price ranges between 44 and 18 and has a mean target at 31.5. With the stocks previous close at 23.03 this is indicating there is a potential upside of 36.8%. The day 50 moving average is 19.64 and the 200 day moving average is 16. The market capitalisation for the company is $90m. Visit the company website at: 0
0
Good news travels fast (but only if you make that happen):
You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.
